Linklaters LLP advises clients in the pharma, healthcare, and financial services industries on merger clearance for M&A, combining work on HSR filings with strong capabilities across DOJ and FTC investigations, including Second Request proceedings, global approval processes, and antitrust litigation relating to mergers. Leveraging its considerable global network, the team seamlessly co-ordinates global approvals in concert with its international offices, including those in the UK and Europe, to effectively represent global clients. Practice head Antonia Sherman, based in Washington DC, is noted for her specialism on obtaining merger clearances both under the U.S. Hart-Scott-Rodino Act and the laws of non-US jurisdictions. In the New York office, Tom McGrath is recommended for his experience in the life sciences and chemicals industries, while Douglas Tween is noted for his litigation capabilities.
Key clients
- Perfetti van Melle
- Novartis International AG
Work highlights
- Represented Novartis on merger control in its acquisition of Chinook for US$3.5bn to strengthen its renal disease pipeline.
- Advising Perfetti van Melle on its US$1.35bn acquisition of the developed markets gum business of Mondelez.